Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Choosing the right accounts and locations for index funds can reduce taxable distributions and improve net returns over time.
15,771 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Gold prices lure investors to miners as a way to gain leveraged exposure to gold. This article compares two different...
Bitcoin faces a pivotal test as Moody’s recession odds rise toward a historic point. Macro signals suggest crypto cou...
Kraft Heinz reports solid free cash flow while store-brand competition erodes volumes, prompting a pivot away from a ...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A personal-finance-focused look at how the next generation must blend grit with adaptability as AI reshapes internshi...
The Midwest multifamily investment sector heating is gaining momentum as rates stabilize and rental demand strengthen...
A new humanoid robot from a major player has people talking. This article breaks down what a rival with a familiar lo...
The federal debt breached $39 trillion this week as lawmakers debated a constitutional fix that failed to pass. The p...
In the past five years, independent science fiction films proved you don’t need a blockbuster budget to tell a powerf...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...
Wall Street predicts these three AI stocks could double within four years as demand for AI infrastructure and memory ...